Effect of rivastigmine on scopolamine-induced memory impairment in rats
- 1 November 1999
- journal article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 383 (3), 231-240
- https://doi.org/10.1016/s0014-2999(99)00643-3
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Dose-dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer's diseaseActa Neurologica Scandinavica, 2009
- Relationship between pharmacodynamic activity and cognitive effects of eptastigmine in patients with Alzheimer's disease*Clinical Pharmacology & Therapeutics, 1996
- An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitorsEuropean Journal of Pharmacology, 1996
- Chapter 53: Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's diseaseProgress in brain research, 1993
- Effects of four non-cholinergic cognitive enhancers in comparison with tacrine and galanthamine on scopolamine-induced amnesia in ratsPsychopharmacology, 1992
- The behavioral effects of heptyl physostigmine, a new cholinesterase inhibitor, in tests of long-term and working memory in rodentsPharmacology Biochemistry and Behavior, 1991
- Patterns of memory failure after scopolamine treatment: Implications for cholinergic hypotheses of dementiaBehavioral and Neural Biology, 1986
- Memory retention: potentiation of cholinergic drug combinations in miceNeurobiology of Aging, 1983
- NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIESBrain, 1976
- A new and rapid colorimetric determination of acetylcholinesterase activityBiochemical Pharmacology, 1961